Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J McCann

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Emergency Medicine|July 21, 2005
Sixth cranial nerve palsySanjay Shewakramani, David J McCann, Stephen H Thomas, et al.
Journal of Clinical Psychopharmacology|August 6, 2015
Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications DevelopmentDavid J McCann, Nancy M Petry, Anders Bresell, et al.
Journal of Clinical Pharmacology|December 5, 2015
Mitigating the Effects of Nonadherence in Clinical TrialsThomas M Shiovitz, Earle E Bain, David J McCann, et al.
Drug and Alcohol Dependence|July 11, 2016
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependenceYossi Gilgun-Sherki, Rom E Eliaz, David J McCann, et al.
Drug and Alcohol Dependence|December 15, 2015
Measures of outcome for stimulant trials: ACTTION recommendations and research agendaBrian D Kiluk, Kathleen M Carroll, Amy Duhig, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Emergency Medicine|July 21, 2005
Sixth cranial nerve palsySanjay Shewakramani, David J McCann, Stephen H Thomas, et al.
Journal of Clinical Psychopharmacology|August 6, 2015
Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications DevelopmentDavid J McCann, Nancy M Petry, Anders Bresell, et al.
Journal of Clinical Pharmacology|December 5, 2015
Mitigating the Effects of Nonadherence in Clinical TrialsThomas M Shiovitz, Earle E Bain, David J McCann, et al.
Drug and Alcohol Dependence|July 11, 2016
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependenceYossi Gilgun-Sherki, Rom E Eliaz, David J McCann, et al.
Drug and Alcohol Dependence|December 15, 2015
Measures of outcome for stimulant trials: ACTTION recommendations and research agendaBrian D Kiluk, Kathleen M Carroll, Amy Duhig, et al.
Pageof 2